Processa Pharmaceuticals (PCSA) Revenue (2012 - 2016)
Processa Pharmaceuticals' (PCSA) quarterly Revenue came in at $5000.0 in Q1 2016, down 84.74% YoY from $32760.0 in Q2 2015, and down 71.43% on a QoQ basis from $17500.0 in Q4 2015.
Processa Pharmaceuticals (PCSA) Revenue (2012 - 2016) Analysis & Trends
Processa Pharmaceuticals (PCSA) has 5 years of Revenue data on file, last reported at $5000.0 in Q1 2016.
- Quarterly Revenue fell 84.74% year-over-year to $5000.0 in Q1 2016, while the trailing twelve-month figure through Dec 2016 was $5000.0 (down 94.31% YoY) and the FY2016 annual result came in at $5000.0, down 95.59% from the prior year.
- Revenue eased to $5000.0 in Q1 2016, from $17500.0 in the prior quarter.
- In the past five years, Revenue ranged from a high of $125910.0 in Q3 2013 to a low of $5000.0 in Q1 2016.
- A 5-year average of $46239.1 and a median of $32105.5 in 2012 frame the typical range for Revenue.
- Annual changes were most pronounced in 2013 — Revenue surged 156.66% — and 2016, when it tumbled 84.74%.
- Tracing PCSA's Revenue over 5 years: stood at $31451.0 in 2012, then soared by 122.85% to $70090.0 in 2013, then plunged by 79.45% to $14400.0 in 2014, then climbed by 21.53% to $17500.0 in 2015, then sank by 71.43% to $5000.0 in 2016.
- The last three Revenue figures came in at $5000.0 (Q1 2016), $17500.0 (Q4 2015), and $17593.0 (Q3 2015), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.29 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 425.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 674.14 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.06 Bn |
| 10 | Processa Pharmaceuticals | 5.93 Mn | 5.93 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2016 | 5,000.00 |
| Dec 31, 2015 | 17,500.00 |
| Sep 30, 2015 | 17,593.00 |
| Jun 30, 2015 | 20,040.00 |
| Mar 31, 2015 | 32,760.00 |
| Dec 31, 2014 | 14,400.00 |
| Sep 30, 2014 | 52,621.00 |
| Jun 30, 2014 | 77,000.00 |
| Mar 31, 2014 | 12,900.00 |
| Dec 31, 2013 | 70,090.00 |
| Sep 30, 2013 | 125,910.00 |
| Jun 30, 2013 | 97,280.00 |
| Mar 31, 2013 | 19,200.00 |
| Dec 31, 2012 | 31,451.00 |
| Sep 30, 2012 | 49,058.00 |
| Jun 30, 2012 | 97,022.00 |